Viewing Study NCT03577704


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-31 @ 8:29 AM
Study NCT ID: NCT03577704
Status: COMPLETED
Last Update Posted: 2023-04-12
First Post: 2018-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module